Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Cardiovascular Effects of Energy Drinks in Healthy Adults

Not Applicable

Completed

Conditions: Cardiovascular System
Energy Drinks
Hemodynamics

Interventions: Other: Energy Drink
Other: Placebo Drink

First Posted Date: 2013-09-12

Last Posted Date: 2022-05-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 25

Registration Number: NCT01940822

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Myocardial Infarction Genes (MI-GENES) Study

Not Applicable

Completed

Conditions: Genomic Risk Communication
Coronary Artery Disease
Myocardial Infarction

Interventions: Other: Genetic Risk Score

First Posted Date: 2013-09-06

Last Posted Date: 2016-05-03

Lead Sponsor: Mayo Clinic

Target Recruit Count: 216

Registration Number: NCT01936675

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Bortezomib, Melphalan, and Total-Body Irradiation Before Stem Cell Transplant in Treating Patients With Multiple Myeloma

Phase 1

Completed

Conditions: DS Stage I Plasma Cell Myeloma
DS Stage II Plasma Cell Myeloma
DS Stage III Plasma Cell Myeloma
Refractory Plasma Cell Myeloma

Interventions: Drug: Bortezomib
Radiation: Total-Body Irradiation
Drug: Melphalan
Procedure: Autologous Bone Marrow Transplantation
Procedure: Autologous Hematopoietic Stem Cell Transplantation
Procedure: Peripheral Blood Stem Cell Transplantation
Other: Laboratory Biomarker Analysis

First Posted Date: 2013-09-05

Last Posted Date: 2018-05-24

Lead Sponsor: Mayo Clinic

Target Recruit Count: 11

Registration Number: NCT01936090

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Technology-enhanced Transitional Care for Rural Palliative Care Patients: A Pilot Study

Not Applicable

Completed

Conditions: Palliative Care
Transitional Care

Interventions: Other: Usual Standard of Care
Behavioral: Technology-Enhanced Transitional Palliative Care

First Posted Date: 2013-09-04

Last Posted Date: 2015-02-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 17

Registration Number: NCT01934413

Locations: 🇺🇸
Mayo Health System, Mankato, Minnesota, United States

Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer

Phase 2

Completed

Conditions: Human Papillomavirus Infection
Stage I Oropharyngeal Squamous Cell Carcinoma
Stage II Oropharyngeal Squamous Cell Carcinoma
Stage III Oropharyngeal Squamous Cell Carcinoma
Stage IVA Oropharyngeal Squamous Cell Carcinoma
Stage IVB Oropharyngeal Squamous Cell Carcinoma

Interventions: Drug: Docetaxel
Radiation: Hyperfractionation
Radiation: Intensity-Modulated Radiation Therapy
Other: Laboratory Biomarker Analysis
Other: Quality-of-Life Assessment

First Posted Date: 2013-08-30

Last Posted Date: 2023-09-21

Lead Sponsor: Mayo Clinic

Target Recruit Count: 81

Registration Number: NCT01932697

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Use of Autologous Bone Marrow Aspirate Concentrate in Painful Knee Osteoarthritis

Phase 1

Completed

Conditions: Bilateral Primary Osteoarthritis of Knee

Interventions: Drug: Autologous Bone Marrow Aspirate Concentrate
Drug: Sterile saline

First Posted Date: 2013-08-29

Last Posted Date: 2017-05-05

Lead Sponsor: Mayo Clinic

Target Recruit Count: 25

Registration Number: NCT01931007

Locations: 🇺🇸
Mayo Clinic Jacksonville, Jacksonville, Florida, United States

Nasal Nitric Oxide Levels in Eosinophilic Esophagitis (EoE)

Completed

Conditions: Eosinophilic Esophagitis

First Posted Date: 2013-08-28

Last Posted Date: 2019-09-30

Lead Sponsor: Mayo Clinic

Target Recruit Count: 50

Registration Number: NCT01929824

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Device: Molecular Breast Imaging
Device: Conventional Mammography
Drug: Technetium (99mTc) sestamibi

First Posted Date: 2013-08-19

Last Posted Date: 2014-08-19

Lead Sponsor: Mayo Clinic

Target Recruit Count: 1638

Registration Number: NCT01925170

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Perfusion Assessment of Wound Closure Techniques in Primary Total Knee Arthroplasty

Not Applicable

Completed

Conditions: Total Knee Arthroplasty

Interventions: Procedure: Running Subcuticular Closure
Procedure: Vertical Mattress Closure
Procedure: Staple Closure

First Posted Date: 2013-08-16

Last Posted Date: 2015-02-16

Lead Sponsor: Mayo Clinic

Target Recruit Count: 45

Registration Number: NCT01924403

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Ultrasound Guided Transversus Abdominis Plane (TAP) vs. Trigger Point Injection (TPI) for Abdominal Wall Pain

Phase 2

Completed

Conditions: Abdominal Pain

Interventions: Drug: Bupivacaine 0.25%
Drug: Triamcinolone

First Posted Date: 2013-07-24

Last Posted Date: 2020-05-14

Lead Sponsor: Mayo Clinic

Target Recruit Count: 62

Registration Number: NCT01906944

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy